Delivery Order SPE2DB20D3103-SPE2DB25FP5Y0
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Azithromycin 500 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with a ceiling value of $16,453.75 and an ultimate completion date of July 25, 2025. The contract was competitively awarded with no set-aside designation, and the place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Azithromycin 500 mg tablets in a quantity of 30 units, with a ceiling value of $2,615.32. This contract utilizes a firm fixed price structure and represents a non-set-aside competitive award. The delivery order is scheduled for ultimate completion by July 21, 2025, with performance to be executed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Azithromycin 500 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $4,486.90 and a completion date of August 1, 2025. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Azithromycin 250 mg tablets in quantities of 30 units, with a ceiling value of $6,311.42. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award based on capability. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Azithromycin 250 mg tablets in quantities of 30 units. This contract, valued at $6,100.26, represents a firm fixed price delivery order with an ultimate completion date of August 1, 2025. The award is non-competitive and carries no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform...
- The Defense Logistics Agency awarded a delivery order valued at $9,828.00 to AmerisourceBergen Drug Corp for the supply of Azithromycin 500 mg tablets (30-count) on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed-price delivery order, awarded without a set-aside designation through competitive procedures, will be fulfilled at the contractor's location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 30-count packages of Azithromycin 500 mg tablets under a firm fixed price contract with a ceiling value of approximately $27.8K. The order, issued on August 5, 2025, with an ultimate completion date of August 6, 2025, represents a competitively awarded, non-set-aside procurement. Performance will be executed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency on July 29, 2025, for the supply of Azithromycin 500 mg tablets in packages of 30 units. This is a firm fixed-price delivery order with a ceiling value of $7,620.00 and an ultimate completion date of July 30, 2025. The contract utilizes no set-aside designation and is competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a $1,526.00 delivery order to AmerisourceBergen Drug Corp for Azithromycin 250 mg tablets (30-count units) on July 25, 2025, with an ultimate completion date of July 28, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Azithromycin 250 mg tablets in quantities of 30 per unit, with a ceiling value of $8,271.78. This competitive award, issued without set-aside designation, is structured as a firm fixed-price delivery order with an ultimate completion date of August 15, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP5Y0Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Azithromycin 500 mg tablets (30-count packaging) with a ceiling value of $9,828.00. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is set to be completed by July 23, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a continuation of AmerisourceBergen's substantial pharmaceutical supply relationship with the federal government. This award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle serves as a comprehensive pharmaceutical support mechanism for military and federal healthcare systems worldwide, enabling AmerisourceBergen to supply a broad range of medications, vaccines, medical devices, and healthcare commodities across multiple therapeutic categories. The company's federal contract portfolio demonstrates consistent capability in fulfilling military pharmaceutical procurement needs through open competition, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.8k | 7/22/25 |